Castle biosciences presents data on decisiondx®-melanoma and decisiondx® diffdx™-melanoma tests at american society of dermatopathology (asdp) 57th virtual annual meeting

Friendswood, texas--(business wire)---- $cstl #asdp2020--castle today announced the presentation of data on two of its skin cancer gene expression profile tests during the 57th meeting of asdp.

CSTL Ratings Summary

CSTL Quant Ranking